Cognitive Testing

Cognitive testing in the context of Alzheimer's Disease and dementia is crucial for early detection and monitoring of cognitive decline. These tests assess various cognitive functions such as memory, attention, language abilities, and problem-solving skills. They help clinicians establish a baseline of cognitive function, track changes over time, and differentiate between normal aging and pathological conditions like Alzheimer's.

Commonly used tests include the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Clock Drawing Test. These assessments provide valuable insights into a person's cognitive abilities and help in formulating personalized care plans. Early identification through cognitive testing allows for timely interventions, potentially slowing down cognitive decline and improving quality of life. Regular monitoring with these tests is essential for adapting care strategies as the disease progresses.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp